Growth Metrics

Thermo Fisher Scientific (TMO) Non-Current Debt (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Non-Current Debt readings, the most recent being $40.1 billion for Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 27.74% to $40.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $40.1 billion, a 27.74% increase, with the full-year FY2025 number at $35.9 billion, up 23.37% from a year prior.
  • Non-Current Debt hit $40.1 billion in Q1 2026 for Thermo Fisher Scientific, up from $35.9 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $40.1 billion in Q1 2026 to a low of $28.2 billion in Q4 2022.
  • Median Non-Current Debt over the past 5 years was $31.2 billion (2024), compared with a mean of $31.3 billion.
  • The widest YoY moves for Non-Current Debt: up 68.39% in 2022, down 10.59% in 2022.
  • Thermo Fisher Scientific's Non-Current Debt stood at $28.9 billion in 2022, then grew by 8.3% to $31.3 billion in 2023, then fell by 7.18% to $29.1 billion in 2024, then increased by 23.37% to $35.9 billion in 2025, then increased by 11.77% to $40.1 billion in 2026.
  • The last three reported values for Non-Current Debt were $40.1 billion (Q1 2026), $35.9 billion (Q4 2025), and $31.9 billion (Q3 2025) per Business Quant data.